- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Swissray to divest Empower in retooling
Swissray International has released more details on its plans to reorganize the company (SCAN 2/18/98). In a move designed to focus the firm on digital imaging, the New York City-based digital radiography developer has signed a letter of intent to
Swissray International has released more details on its plans to reorganize the company (SCAN 2/18/98). In a move designed to focus the firm on digital imaging, the New York City-based digital radiography developer has signed a letter of intent to sell its Swissray Empower U.S. film and x-ray accessories division to distributor E.M. Parker, based in Wilmington, MA.
Terms of the transaction are still being negotiated, with a completion date expected during the current fiscal year, according to Swissray. Swissray had acquired the Empower business in April 1997 as part of the firm's attempt to offer a wide range of products and services to customers.
In other reorganization developments, the company's board of directors has decided to restructure its senior management as part of a plan to grow Swissray beyond a developmental-stage company, said Ruedi Laupper, chairman. A search is under way for a new CEO and CFO. Laupper, who previously also held the titles of president and CEO, retains primary responsibility for day-to-day operations.
In other company news, Swissray has sold another AddOn-Multi-System, to Dutchess Radiology Associates of Poughkeepsie, NY. Financial terms of the sale were not released.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
